세계의 포스트바이오틱 외용제 시장 예측(-2032년) : 제품 유형별, 유효 성분별, 용도별, 최종사용자별, 유통 채널별, 지역별 분석

According to Stratistics MRC, the Global Postbiotic Topicals Market is accounted for $138.2 million in 2025 and is expected to reach $267.7 million by 2032, growing at a CAGR of 9.9% during the forecast period. Postbiotic topicals are skincare formulations infused with non-living microbial byproducts such as enzymes, peptides, and metabolites that support skin health. Postbiotics do not contain live bacteria, making them more stable and suitable for topical use. These bioactive compounds help reinforce the skin barrier, reduce inflammation, and promote a balanced microbiome. Widely used in dermatology and cosmetic applications, postbiotic topicals offer targeted benefits for sensitive, acne-prone, or aging skin without the risks associated with live cultures.

Market Dynamics:

Driver:

Rising prevalence of skin conditions like acne, eczema, and sensitivity

Acne, eczema, and sensitivity conditions have heightened consumer awareness around microbiome-friendly skincare, prompting interest in non-irritating, barrier-supportive formulations. Postbiotics offer anti-inflammatory and soothing benefits without the instability of live cultures, making them ideal for sensitive skin. This trend is further reinforced by clinical endorsements and growing demand for clean-label products. As consumers seek targeted relief, postbiotic topicals are gaining traction across both therapeutic and cosmetic applications.

Restraint:

High production costs and complex manufacturing processes

Unlike conventional actives, postbiotics require precise fermentation, purification, and stabilization steps to retain efficacy. These processes often demand specialized equipment and skilled personnel, increasing operational overheads. Additionally, regulatory compliance and quality assurance protocols add to the cost burden. For emerging brands and formulators, these barriers can limit scalability and price competitiveness, thereby slowing broader market penetration despite rising consumer interest.

Opportunity:

Development of innovative postbiotic blends for targeted skin concerns

By combining bioactive metabolites with complementary ingredients, brands can create multifunctional products that address both aesthetic and therapeutic needs. Innovations in encapsulation and delivery systems are enhancing stability and skin absorption, further expanding application potential. Moreover, consumer demand for microbiome-supportive skincare is encouraging R&D investments. This opens avenues for differentiation and premium positioning, especially in clinical-grade and wellness-focused product lines.

Threat:

Intense competition from other skincare active ingredients

The postbiotic topicals market is challenged by intense competition from established skincare actives such as retinoids, peptides, ceramides, and niacinamide. These ingredients have long-standing consumer trust, extensive clinical validation, and widespread availability across price tiers. As a result, postbiotics must compete not only on efficacy but also on cost, familiarity, and brand loyalty. Furthermore, marketing claims around microbiome health are still evolving, which may hinder consumer understanding.

Covid-19 Impact:

The COVID-19 pandemic initially disrupted supply chains and manufacturing operations for postbiotic topicals, delaying product launches and limiting ingredient availability. However, the crisis also accelerated consumer interest in skin health and immunity, driving demand for microbiome-supportive formulations. Increased screen time and mask usage led to widespread skin irritation, prompting a shift toward barrier-repair and anti-inflammatory products. E-commerce growth and digital skincare consultations further supported market recovery.

The creams & lotions segment is expected to be the largest during the forecast period

The creams & lotions segment is expected to account for the largest market share during the forecast period as creams and lotions remain the most preferred format for postbiotic topical delivery due to their ease of application, skin compatibility, and versatility across age groups. These formats allow for effective dispersion of bioactive compounds and are widely accepted in both therapeutic and cosmetic routines. Their ability to hydrate, soothe, and reinforce the skin barrier makes them ideal carriers for postbiotic ingredients. Moreover, brands are increasingly integrating postbiotics into daily-use moisturizers and serums, reinforcing their dominance in the market.

The anti-aging & barrier repair segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the anti-aging & barrier repair segment is predicted to witness the highest growth rate driven by rising consumer demand for skin longevity and resilience. Postbiotics are gaining recognition for their role in enhancing cellular renewal, reducing oxidative stress, and fortifying the skin's microbiome. These benefits align with the growing preference for non-invasive, microbiome-friendly anti-aging solutions. Additionally, postbiotics offer a gentler alternative to harsh actives, making them suitable for mature and sensitive skin. This segment's growth is further supported by clinical studies and premium product launches.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share due to its advanced skincare industry, high consumer awareness, and robust distribution networks. The region benefits from strong R&D capabilities and early adoption of microbiome science and growing preference for clean-label and functional skincare boosts this regions market. Moreover, leading brands and dermatologists in the U.S. and Canada are actively promoting postbiotic formulations, further driving market penetration.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR owing to rising disposable incomes, expanding beauty consciousness, and increasing demand for skin health solutions. The region's dynamic e-commerce landscape and influencer-driven marketing are accelerating product adoption. Additionally, local manufacturers are investing in postbiotic R&D, contributing to cost-effective and culturally tailored formulations. This momentum positions Asia Pacific as a key growth engine for the market.

Key players in the market

Some of the key players in Postbiotic Topicals Market include Cargill, Incorporated, Archer Daniels Midland Company, Kerry Group plc, dsm-firmenich, Associated British Foods plc, BASF SE, Novonesis, International Flavors & Fragrances Inc., MCLS Europe B.V., Lesaffre Group, Lallemand Inc., Sami-Sabinsa Group Limited, CJ CheilJedang Corporation, Biotenova Sdn. Bhd., Bioprox Healthcare, and Church & Dwight Co., Inc.

Key Developments:

In October 2025, Cargill has conducted human clinical trials highlighting their postbiotic raw material EpiCor, a dried fermentate from Saccharomyces cerevisiae. Results show anti-inflammatory properties and positive effects on skin inflammation when applied topically, reducing microvascular inflammatory responses and irritation in skin models.

In June 2025, dsm-firmenich Animal Nutrition & Health has announced the launch of GutServ(R) Biotics, an innovative postbiotic solution designed to support piglet health, resilience and performance.

In February 2025, ADM a global leader in innovative solutions from nature, announced today its agreement with Asahi Group Foods Corporation, a leading food company headquartered in Japan, to exclusively market and distribute Asahi Group's proprietary lactic acid-based postbiotic, Lactobacillus gasseri CP2305.

Product Types Covered:

• Creams & Lotions
• Serums & Concentrates
• Gels & Ointments
• Masks & Patches
• Sprays & Mists
• Other Product Types

Active Ingredients Covered:

• Short-chain fatty acid (SCFA)-based postbiotics
• Bacterial lysates & cell-free supernatants
• Exopolysaccharides & polysaccharide fractions
• Fermentation-derived metabolites
• Blends & Multi-active Formulations

Applications Covered:

• Sensitive & Redness-prone Skin
• Atopic Dermatitis & Eczema adjuncts
• Acne & Sebum Regulation
• Anti-Aging & Barrier Repair
• Wound Healing / Post-procedural Care
• Hyperpigmentation & Tone Correction

End Users Covered:

• Dermatology Clinics & Prescribable Treatments
• Dermatocosmetic Brands & OTC Retail
• Beauty & Personal Care
• E-commerce / D2C brands
• Spas & Professional Aesthetics

Distribution Channels Covered:

• Pharmacies & Drugstore Chains
• Beauty Retailers & Department Stores
• E-Commerce Marketplaces & Brand Websites
• Professional Channels
• Direct Sales & Subscription Models

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Postbiotic Topicals Market, By Product Type

• 5.1 Introduction
• 5.2 Creams & Lotions
• 5.3 Serums & Concentrates
• 5.4 Gels & Ointments
• 5.5 Masks & Patches
• 5.6 Sprays & Mists
• 5.7 Other Product Types

6 Global Postbiotic Topicals Market, By Active Ingredient

• 6.1 Introduction
• 6.2 Short-chain fatty acid (SCFA)-based postbiotics
• 6.3 Bacterial lysates & cell-free supernatants
• 6.4 Exopolysaccharides & polysaccharide fractions
• 6.5 Fermentation-derived metabolites
• 6.6 Blends & Multi-active Formulations

7 Global Postbiotic Topicals Market, By Application

• 7.1 Introduction
• 7.2 Sensitive & Redness-prone Skin
• 7.3 Atopic Dermatitis & Eczema adjuncts
• 7.4 Acne & Sebum Regulation
• 7.5 Anti-Aging & Barrier Repair
• 7.6 Wound Healing / Post-procedural Care
• 7.7 Hyperpigmentation & Tone Correction

8 Global Postbiotic Topicals Market, By End User

• 8.1 Introduction
• 8.2 Dermatology Clinics & Prescribable Treatments
• 8.3 Dermatocosmetic Brands & OTC Retail
• 8.4 Beauty & Personal Care
• 8.5 E-commerce / D2C brands
• 8.6 Spas & Professional Aesthetics

9 Global Postbiotic Topicals Market, By Distribution Channel

• 9.1 Introduction
• 9.2 Pharmacies & Drugstore Chains
• 9.3 Beauty Retailers & Department Stores
• 9.4 E-Commerce Marketplaces & Brand Websites
• 9.5 Professional Channels
• 9.6 Direct Sales & Subscription Models

10 Global Postbiotic Topicals Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Cargill, Incorporated
• 12.2 Archer Daniels Midland Company
• 12.3 Kerry Group plc
• 12.4 dsm-firmenich
• 12.5 Associated British Foods plc
• 12.6 BASF SE
• 12.7 Novonesis
• 12.8 International Flavors & Fragrances Inc.
• 12.9 MCLS Europe B.V.
• 12.10 Lesaffre Group
• 12.11 Lallemand Inc.
• 12.12 Sami-Sabinsa Group Limited
• 12.13 CJ CheilJedang Corporation
• 12.14 Biotenova Sdn. Bhd.
• 12.15 Bioprox Healthcare
• 12.16 Church & Dwight Co., Inc.